Drug · DIN 02478498
RAYALDEE
MODIFIED-RELEASE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 9, 2023.
- Drug Identification Number (DIN)
- 02478498
- Company (DIN owner)
- Eirgen Pharma LimitedWaterford, --, Ireland
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Calcifediol A11CC06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CALCIFEDIOL | 30 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 9, 2023: NOC 30106New Drug Submission (NDS) · Administrative: Change in Product Ownership
- July 10, 2018: NOC 21063New Drug Submission (NDS)